Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on X:
“Cribriform prostate cancer often hides from standard MRI. But its metabolic fingerprint, lipid biosynthesis, doesn’t.
[¹¹C]acetate PET/CT and ¹H-MRSI offering a new imaging path. Early, better detection. More informed care.”
Title: Spatial metabolomics informs the use of clinical imaging for improved detection of cribriform prostate cancer
Authors: Nikita Sushentsev, Gregory Hamm, Roido Manavaki, Mary A. McLean, Jonathan Birchall, Dmitry Soloviev, David Y. Lewis, Luigi Aloj, Lucy Flint, Aleksandr Zakirov, Ian G. Mills, Vincent J. Gnanapragasam, Anne Y. Warren, Simon T. Barry, Richard J. A. Goodwin, Ferdia A. Gallagher, Tristan Barrett
More posts featuring Yüksel Ürün.